ID26335A - Metoda untuk mencegah restenosis dengan menggunakan tokotrienol - Google Patents

Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Info

Publication number
ID26335A
ID26335A IDW20001179A ID20001179A ID26335A ID 26335 A ID26335 A ID 26335A ID W20001179 A IDW20001179 A ID W20001179A ID 20001179 A ID20001179 A ID 20001179A ID 26335 A ID26335 A ID 26335A
Authority
ID
Indonesia
Prior art keywords
tokotrienol
preventing restenosis
restenosis
preventing
Prior art date
Application number
IDW20001179A
Other languages
English (en)
Indonesian (id)
Inventor
Ronald H Lane
F Howard Schneider
Original Assignee
Lipogenic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenic Inc filed Critical Lipogenic Inc
Publication of ID26335A publication Critical patent/ID26335A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Pyrane Compounds (AREA)
IDW20001179A 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol ID26335A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97170397A 1997-11-17 1997-11-17

Publications (1)

Publication Number Publication Date
ID26335A true ID26335A (id) 2000-12-14

Family

ID=25518699

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001179A ID26335A (id) 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Country Status (6)

Country Link
EP (1) EP1037628A4 (fr)
JP (1) JP2001522880A (fr)
AU (1) AU746369B2 (fr)
CA (1) CA2310232A1 (fr)
ID (1) ID26335A (fr)
WO (1) WO1999025336A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1270004B1 (fr) * 2000-03-31 2010-06-09 Eisai R&D Management Co., Ltd. Utilisation du gamma-tocotrienol comme diuretique
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
EP2324866B1 (fr) 2002-07-12 2014-06-18 Cook Medical Technologies LLC Ballons d'angioplastie revêtis d'agents pharmaceutiques en forme expansée
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
WO2005039443A2 (fr) 2003-10-21 2005-05-06 Medlogics Device Corporation Therapie par gamma-tocopherol pour prevenir la restenose
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
MX359292B (es) 2005-06-01 2018-09-24 Bioelectron Tech Corp Sustancias terapeuticas activas redox para el tratamiento de enfermedades mitocondriales y otras condiciones y modulacion de biomarcadores de energia.
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (fr) 2005-10-15 2007-04-26 Atrium Medical Corporation Gels hydrophobes reticules pour revetements bioabsorbables de vecteur de medicament
CA2635280C (fr) 2006-02-22 2017-12-12 Edison Pharmaceuticals, Inc. Variants a chaines laterales d'agents therapeutiques ayant une activite oxydoreductrice pour le traitement de maladies mitochondriales et d'autres conditions et pour la modulationde biomarqueurs energetiques
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057328A2 (fr) 2006-11-06 2008-05-15 Atrium Medical Corporation Dispositif de séparation de tissu avec support renforcé pour mécanismes d'ancrage
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
WO2011008393A2 (fr) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucléation de ballons d’administration de médicament pour fournir une taille et une densité des cristaux améliorées
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
DK2470168T3 (en) 2009-08-26 2018-05-07 Bioelectron Tech Corp PROCEDURES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCAM
EP2593141B1 (fr) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile
WO2012031236A1 (fr) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Procédé d'enrobage de ballonnets d'administration de médicaments utilisant une mémoire d'enveloppe induite par la chaleur
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
AU2013290761A1 (en) * 2012-07-19 2015-02-05 The Ohio State University Method of ameliorating clotting pathologies and related materials and methods
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0543417A1 (fr) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotriènols et composés sembles à tocotriènol et méthodes pour leur utilisation
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
EP0669132A1 (fr) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Composition pharmaceutique à la vitamine E et à l'acetylsalicylate pour le traitement et la prévention de l'atherosclerosis

Also Published As

Publication number Publication date
WO1999025336A1 (fr) 1999-05-27
EP1037628A4 (fr) 2002-08-21
CA2310232A1 (fr) 1999-05-27
AU1590299A (en) 1999-06-07
JP2001522880A (ja) 2001-11-20
AU746369B2 (en) 2002-04-18
EP1037628A1 (fr) 2000-09-27

Similar Documents

Publication Publication Date Title
ID26335A (id) Metoda untuk mencegah restenosis dengan menggunakan tokotrienol
IS8368A (is) Ný aðferð
FI102426B1 (fi) Menetelmä muistin toteuttamiseksi
DE69830295D1 (de) Steuerungsverfahren
FI102424B1 (fi) Menetelmä muistin toteuttamiseksi
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
EE03801B1 (xx) Stent
FI971620A (fi) Autentikointimenetelmä
DE69817186D1 (de) Diaminorhodamin-derivate
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI102425B1 (fi) Menetelmä muistin toteuttamiseksi
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE69815975D1 (de) Steuerungsverfahren
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
IS5106A (is) Ný aðferð
DE69816734D1 (de) Steuerungsverfahren
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
FI974067A0 (fi) Process foer cellulasbehandling
FI102961B (fi) Menetelmä tuhkan käsittelemiseksi
ID21138A (id) Teknologi film-tipis untuk head-drum
FI970906A0 (fi) Säätelymenetelmä